KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Q3 2025 value amounting to 1.26.

  • Rigel Pharmaceuticals' Asset Utilization Ratio rose 678.35% to 1.26 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.26, marking a year-over-year increase of 678.35%. This contributed to the annual value of 1.28 for FY2024, which is 3718.52% up from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Asset Utilization Ratio stood at 1.26 for Q3 2025, which was up 678.35% from 1.4 recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Asset Utilization Ratio registered a high of 1.4 during Q2 2025, and its lowest value of 0.54 during Q1 2022.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 1.0 (2023), whereas its average is 0.97.
  • As far as peak fluctuations go, Rigel Pharmaceuticals' Asset Utilization Ratio plummeted by 3454.51% in 2022, and later skyrocketed by 8713.38% in 2023.
  • Quarter analysis of 5 years shows Rigel Pharmaceuticals' Asset Utilization Ratio stood at 0.84 in 2021, then grew by 14.09% to 0.96 in 2022, then rose by 4.45% to 1.01 in 2023, then rose by 17.57% to 1.18 in 2024, then increased by 6.25% to 1.26 in 2025.
  • Its last three reported values are 1.26 in Q3 2025, 1.4 for Q2 2025, and 1.19 during Q1 2025.